Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Dexanabinol , neuroprotection

Brewster ME, Pop E, Foltz RL, Reuschel S, Griffith W, Amselem S, Biegon A. (1997). Clinical pharmacokinetics of escalating i.v. doses of dexanabinol (HU211), a neuroprotectant agent, in normal volunteers. IntJ Clin Pharmacol Ther. 35 9361-65. [Pg.556]

Shohami, E., Gallily, R., Mechoulam, R., Bass, R., Ben-Hur, T. (1997). Review. Cytokine production in the brain following closed head injury dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J. Neuroim-munol. 72(2) 169-77. [Pg.963]

Darlington CL (2003) Dexanabinol a novel cannabinoid with neuroprotective properties. IDrugs 6 976-979... [Pg.41]

Shohami E, Mechoulam R (2000) Dexanabinol (HU-211) a nonpsychotropic cannabinoid with neuroprotective properties. Drug Dev Res 50 211-215... [Pg.245]

Pop, E., Rachwal, B., Rachwal, S., Vlasak, J., Brewster, M. E., and Prokai, L. (1998) Synthesis of deuterated dexanabinol, a nonpsychotropic cannabinoid with neuroprotective properties. J. Labelled Compd. Pharm. 41, 885-897. [Pg.145]

See other pages where Dexanabinol , neuroprotection is mentioned: [Pg.439]    [Pg.199]    [Pg.232]    [Pg.953]    [Pg.235]    [Pg.1070]    [Pg.236]    [Pg.1037]   


SEARCH



Dexanabinol

Neuroprotectant

Neuroprotectants

Neuroprotection

Neuroprotective

© 2024 chempedia.info